CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: nomifensine
Accession: CHEBI:116225
browse the term
Definition: An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Synonyms: exact_synonym: 2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-8-amine
related_synonym: 2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine; 8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline; D,L-nomifensine; Formula=C16H18N2; InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3; InChIKey=XXPANQJNYNUNES-UHFFFAOYSA-N; Nomifenison; Nomifensin; Nomiphensine; R/S-nomifensine; SMILES=CN1CC(c2ccccc2)c2cccc(N)c2C1; nomifensina; nomifensinum
xref: Beilstein:484561; CAS:24526-64-5; DrugBank:DB04821; Drug_Central:1958; LINCS:LSM-4388
xref_mesh: MESH:D009627
xref: PMID:1502708; PMID:24766210; PMID:7189402; Reaxys:484561
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Nomifensine results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Nomifensine results in increased expression of FOS protein
CTD
PMID:10904129
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Il24
interleukin 24
increases expression
ISO
Nomifensine results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Met
MET proto-oncogene, receptor tyrosine kinase
decreases expression
ISO
Nomifensine results in decreased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
Nomifensine results in increased expression of PID1 mRNA
CTD
PMID:32816093
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Nomifensine results in decreased expression of PTGS2 mRNA
CTD
PMID:32816093
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Slc18a2
solute carrier family 18 member A2
affects binding
ISO
Nomifensine binds to SLC18A2 protein
CTD
PMID:7912402
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Slc6a3
solute carrier family 6 member 3
multiple interactions
EXP ISO
Nomifensine inhibits the reaction [Rotenone results in decreased expression of SLC6A3 protein] [Nomifensine results in decreased activity of SLC6A3 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium; Nomifensine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine]
CTD
PMID:18206288 PMID:18289173 PMID:20875051
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
multiple interactions
ISO
Nomifensine binds to and results in decreased activity of SLC6A4 protein
CTD
PMID:16272152
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
ISO
Nomifensine results in increased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all